Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S R Burger
IL-2-based Immunotherapy After Autologous Transplantation for Lymphoma and Breast Cancer Induces Immune Activation and Cytokine Release: A Phase I/Ii Trial
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Phase I Clinical Trial Combining Imatinib Mesylate and IL-2
OncoImmunology
Oncology
Allergy
Immunology
Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial
British Journal of Haematology
Hematology
Autologous Tumor Cell Vaccination Combined With Systemic CpG-B and IFN-α Promotes Immune Activation and Induces Clinical Responses in Patients With Metastatic Renal Cell Carcinoma: A Phase II Trial
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase I/Ii Trial of TLR-7 Agonist Immunotherapy in Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Monoclonal Antibodies and Autologous Stem Cell Transplantation for Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Transactivation of Interleukin 2 and Its Receptor Induces Immune Activation in Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy: Pathogenic Implications and a Rationale for Immunotherapy.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Breast Conservation Therapy With Tumor Bed Brachytherapy Alone in Stage I Breast Cancer-Results of a Phase II Trial
Kansas Journal of Medicine
